Conformis Reports Second Quarter 2021 Financial Results
04. August 2021 16:05 ET
|
Conformis, Inc.
BILLERICA, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
14. Juli 2021 17:45 ET
|
Conformis, Inc.
BILLERICA, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Release Second Quarter 2021 Financial Results on August 4, 2021
01. Juli 2021 17:00 ET
|
Conformis, Inc.
BILLERICA, Mass., July 01, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the second quarter ended June 30, 2021 after the...
Conformis, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
18. Mai 2021 08:15 ET
|
Conformis, Inc.
BILLERICA, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference
12. Mai 2021 18:10 ET
|
Conformis, Inc.
BILLERICA, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. Announces 510(k) Clearance for Identity Imprint™ Knee Replacement System
10. Mai 2021 07:30 ET
|
Conformis, Inc.
BILLERICA, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration for the Company’s Identity Imprint Knee...
Conformis Reports First Quarter 2021 Financial Results
05. Mai 2021 16:05 ET
|
Conformis, Inc.
BILLERICA, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System
01. März 2021 17:45 ET
|
Conformis, Inc.
BILLERICA, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) today announced the clearance of its patient-specific iTotal® PS total knee replacement system by the Therapeutic...
Conformis, Inc. Announces Proposed Public Offering of Common Stock
11. Februar 2021 16:01 ET
|
Conformis, Inc.
BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an underwritten public offering. Conformis...
Conformis, Inc. and SITES Medical Announce Development & Supply Agreement
21. Januar 2021 16:15 ET
|
Conformis, Inc.
BILLERICA, Mass. and COLUMBIA CITY, Ind., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) and SITES Medical, a firm dedicated to inventing and de-risking new orthopedic medical...